Immediate Impact
50 standout
Citing Papers
GPCR drug discovery: new agents, targets and indications
2025 Standout
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Works of Hitomi Oki being referenced
Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Hitomi Oki | 117 | 69 | 1 | 204 | 91 | 6 | 363 | |
| A. R. Green | 181 | 85 | 1 | 164 | 90 | 6 | 341 | |
| Szabolcs Orosz | 147 | 62 | 170 | 127 | 7 | 347 | ||
| Tsuyoshi Hirose | 175 | 63 | 167 | 92 | 15 | 403 | ||
| C. Härnryd | 130 | 50 | 194 | 82 | 8 | 304 | ||
| Hitomi Akazawa | 103 | 183 | 237 | 52 | 4 | 397 | ||
| Takaichi Miwa | 188 | 44 | 1 | 164 | 184 | 7 | 395 | |
| M. Maffini | 77 | 66 | 1 | 185 | 56 | 6 | 376 | |
| Muhammad Sajjad Shahid | 129 | 50 | 2 | 141 | 149 | 13 | 391 | |
| Tom Ramsey | 83 | 81 | 1 | 263 | 63 | 15 | 409 | |
| Lin‐Whei Chuang | 218 | 62 | 1 | 80 | 110 | 11 | 406 |
All Works
Loading papers...